AlphaYouTM
Congress trade
Rep. Thomas MacArthur (R-NJ) sold $15K-$50K of Biogen Idec Inc. (BIIB) stock
Thomas MacArthur, U.S. Representative (R-NJ), disclosed a sale of Biogen Idec Inc. (BIIB) stock worth $15K-$50K in a STOCK Act filing on Mar 11, 2015.
The trade happened on Feb 4, 2015, 35 days before it was made public.
BIIB has moved -43.8% since the trade date, from $391.12 to $219.88 (Oct 2, 2026 close).
- Traded
- Feb 4, 2015
- Disclosed
- Mar 11, 2015
- Filing delay
- 35 days
- Price since
- -43.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- SellHYG$100K-$250KMar 11, 2015
- SellRHHBY$100K-$250KMar 11, 2015
- SellHTHIY$50K-$100KMar 11, 2015
- BuyIEMG$50K-$100KMar 11, 2015
- BuyIWD$50K-$100KMar 11, 2015
- BuyIWF$50K-$100KMar 11, 2015
- BuyADDYY$15K-$50KMar 11, 2015
- BuyFCX$15K-$50KMar 11, 2015
- BuyFCX$15K-$50KMar 11, 2015
- SellHYG$15K-$50KMar 11, 2015
- SellHYG$15K-$50KMar 11, 2015
- BuyINTC$15K-$50KMar 11, 2015
- BuyNEE$15K-$50KMar 11, 2015
- BuyQCOM$15K-$50KMar 11, 2015
- SellTSM$15K-$50KMar 11, 2015
- SellXLS$15K-$50KMar 11, 2015
- BuyAEL$1K-$15KMar 11, 2015
- BuyAFL$1K-$15KMar 11, 2015
- BuyAXP$1K-$15KMar 11, 2015
- BuyCL$1K-$15KMar 11, 2015
More BIIB insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.